Cannabis Battle! 2 Pot Stocks With Very Different Futures

The pot industry is growing at a rapid pace, but choosing winning stocks is getting harder. Learn what makes Green Organic Dutchman (TSX:TGOD) a sell and Cronos Group Inc (TSX:CRON)(NYSE:CRON) a buy.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

The cannabis market should continue to grow for the next decade and beyond. Many analysts believe the global market could surpass $100 billion in sales by 2030. In order to meet surging demand, pot companies have been ramping their capacity and infrastructure at breakneck speeds. They’ve also been working to secure valuable partnerships to accelerate market adoption.

Even if the pot industry continues to take off, however, it’s no guarantee that every cannabis company will succeed. Consider the solar industry. For 10 years straight, solar demand has continued to mount, yet the industry has seen dozens of bankruptcies.

The early internet was also a good example. In 1999, the internet had the vast majority of its growth days ahead of it, but that year saw hundreds of dot-com businesses disappear.

If you want to succeed investing in the marijuana industry, you’ll need to know which strategies will work and which ones won’t. There are no better examples of this than Green Organic Dutchman (TSX:TGOD) and Cronos Group Inc (TSX:CRON)(NYSE:CRON).

Avoid commoditization

If you invest in the pot market, know one thing: commoditization will ruin the party. At the end of the day, there’s not much differentiation between cannabis production. Compare it to something like wheat, corn, or soy, all of which are grown by commoditized farms fetching a market price.

Regulation is keeping supply limited, but we’ve already seen how cannabis pricing can collapse due to surging numbers of growers. In 2018, Oregon was reportedly “drowning in one million pounds of excess weed,” pushing down prices to historically low levels.

If you want to avoid commoditization, avoid companies like Green Organic, as Green Organic is positioned as a pure grower, with no differentiation apart from its organic focus.

While organic cannabis has fetched a higher price, it’s just as susceptible to steep pricing declines. Green Organic’s lack of differentiation was demonstrated when its former partner, Aurora Cannabis Inc, opted to terminate its agreement to buy 20% of its produce, choosing instead to source the cannabis elsewhere.

Wherever pot pricing goes, so too will Green Organic. That’s a risky bet as commoditization looms. Instead, choose companies that can better dictate their own future.

Brands and influence

Soda is a commodity, but you wouldn’t be able to tell looking at Coca-Cola Co. As a $250 billion behemoth, Coca-Cola has demonstrated that it can sustain high margins for decades at a time. Another example is cigarettes.

Tobacco is largely commoditized, yet firms like Altria Group Inc (formerly Philip Morris) continue to rake in billions every year. Learning from firms like Altria is critical for any pot company looking to capitalize long term. Fortunately, one cannabis firm has direct access.

Last year, Altria and Cronos agreed to a $1.8 billion partnership that should align each companies interest for the next decade and beyond. Altria is the most experienced partner conceivable when it comes to navigating a highly regulated, increasingly commoditized industry.

If any cannabis company succeeds, it should be Cronos. If Green Organic’s stock will follow cannabis pricing, Cronos’ stock should follow industry-wide growth. That’s a much better bet.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »

Marijuana plant and cannabis oil bottles isolated
Cannabis Stocks

Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030

Quality cannabis stocks such as Green Thumb and Cresco Labs are positioned to deliver outsized gains to shareholders in 2024…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

The Big Mistake I See Cannabis Investors Making Over and Over Again

The news of marijuana slated to be legalized next year has seen a boost for cannabis investors, but they must…

Read more »

cup of cappuccino with a sad face
Cannabis Stocks

A TSX Stock I’d Avoid at All Costs

Despite posting a massive surge in share prices, Canopy Growth (TSX:WEED) is a stock you might be better off steering…

Read more »

edit Jars of marijuana
Cannabis Stocks

4 Reasons Canopy Growth Stock Looks Like a Screaming Buy

Canopy Growth (TSX:WEED) stock has a lot going for it lately, but there are still more hurdles ahead. Even so,…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

1 Cannabis Stock to Buy Hand Over Fist and 1 to Avoid

For investors looking for a cannabis stock to buy and one to sell, here are my top two picks in…

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

What’s Going on With Canadian Pot Stocks?

Canadian cannabis stocks exposed to the U.S. saw a boost in share price this week from rumours that rescheduling of…

Read more »